SEC Filing Summary: CopyTele, Inc. (10-Q)
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for CopyTele, Inc. (not Anixa Biosciences Inc.) for the period ended April 30, 1998. The company is classified as a Development Stage Enterprise incorporated in 1982. Its principal activities involve the development, production, and marketing of the MAGICOM(R) 2000, a telephone-based telecommunications product featuring E-Paper(TM) flat panel display technology, and the MAGIC PRINTER. The company also operates a 55% owned joint venture in Shanghai, China (SCE).
Key Financial Metrics
| Metric | Six Months Ended April 30, 1998 |
Six Months Ended April 30, 1997 |
Inception to April 30, 1998 |
|---|---|---|---|
| Revenue (Sales) | $0 | $0 | $0 |
| Net Loss | ($3,751,887) | ($2,981,425) | ($38,310,842) |
| Loss Per Share (Basic) | ($0.06) | ($0.05) | ($0.83) |
| Research & Development Expenses | $2,106,000 | $2,021,000 | $26,491,000 |
| Cash and Equivalents (Ending) | $7,957,329 | $18,475,690 | N/A |
| Working Capital | $13,712,000 | $16,990,000 | N/A |
| Debt | $0 (Company) | $0 (Company) | N/A |
Note: The Joint Venture (SCE) holds short-term loans of approximately $999,321 as of April 30, 1998.
Material Changes vs. Prior Period
- Increased Net Loss: The net loss for the six months ended April 30, 1998, increased by approximately $770,000 compared to the same period in 1997.
- Expense Growth: Selling, general, and administrative expenses (including R&D) rose by approximately $545,000 year-over-year. This was driven by increased salaries for marketing and engineering personnel, higher professional fees related to the Joint Venture and potential SIEC agreement, and stock-based compensation for consultants ($180,000).
- Joint Venture Loss: The company's share of the loss from the Shanghai Joint Venture increased by approximately $49,000 to $207,000 for the six-month period, attributed to manufacturing costs absorbed over limited production volumes and quality management implementation.
- Declining Liquidity: Cash and cash equivalents decreased by approximately $4.37 million during the six-month period. Working capital declined by approximately $3.28 million primarily due to the period's operating loss.
- Interest Income: Interest income decreased by approximately $226,000 due to a significant reduction in average funds available for investment.
Outlook, Risks, and Management Commentary
- Revenue Recognition: The company has made limited sales to distributors but has deferred revenue recognition pending sustained acceptance by end-users. There is no assurance of future significant revenue or profitability.
- Liquidity Outlook: Management believes current funds are sufficient to maintain development efforts into the first quarter of fiscal 2000, assuming continued salary waivers by senior executives and collection of amounts due from the Joint Venture. However, additional funds may be required for R&D and Joint Venture participation.
- Strategic Discussions: The company is in preliminary, non-binding discussions with Shanghai Instrumentation and Electronics Holding Group Company (SIEC) regarding a potential strategic alliance or equity exchange. No formal agreement exists.
- Risks: Key risks include the ability of distributors to market products, production capabilities of the Joint Venture, foreign currency volatility, and the potential for competitive products to render the company's technology obsolete.
Investor Verification Checklist
- Revenue Deferral: Verify the specific criteria and timeline for recognizing revenue from distributor sales, as current sales are not yet recognized.
- Joint Venture Solvency: Assess the financial health of the Shanghai Joint Venture (SCE), which is incurring losses and holds significant debt, and the collectability of the ~$4.9 million receivable due from SCE.
- Executive Compensation Waivers: Confirm the status of the salary and pension benefit waivers by the Chairman, President, and senior personnel, as the liquidity forecast relies on these continuing.
- Product Market Acceptance: Evaluate the actual end-user adoption rates of the MAGICOM(R) 2000 and MAGIC PRINTER to determine if the "development stage" status will change.
- Capital Requirements: Review the potential need for additional capital contributions to the Joint Venture, which may require up to $25 million total depending on business activity.